Adam M Veness
CIK 1778623 · SVP, General Counsel and Sec. · last filed 2026-02-04
Adam M Veness is a SVP, General Counsel and Sec. who has filed 21 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for DNTH, was dated Feb 4, 2026. Across all open-market trades the lifetime net is −$2.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
21
-$2.40M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNTH | SVP, General Counsel and Sec. | — | $82.07 | — | $0 | 4 | 2026-02-04 |
| Cyteir Therapeutics, Inc. (CYT) Delisted | General Counsel | — | $3.02 | — | $0 | 2 | 2023-02-07 |
| ACCELERON PHARMA INC (XLRN) Delisted | SVP, General Counsel and Sec. | 0 | $178.75 | $0 | -$2.40M | 15 | 2021-11-22 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-04 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2025-02-04 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2024-05-28 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2024-01-26 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2023-02-07 | Cyteir Therapeutics, Inc. (CYT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-04 | Cyteir Therapeutics, Inc. (CYT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-22 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | −23,423 | $0 | EDGAR |
| 2021-11-12 | ACCELERON PHARMA INC (XLRN) Delisted | Exer (M) | +4,500 | $132.2K | EDGAR |
| 2021-09-22 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | — | -$781.2K | EDGAR |
| 2021-09-09 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | −2,000 | -$259.6K | EDGAR |